Legislation Roundup: Pharma Data Protection, and Beijing and Guangdong Data Transfers

Innovative drugs are accorded a six-year data protection period. Beijing and Guangdong add more details to their data transfer negative lists.

By Susan Mok

Healthcare

National Medical Products Administration, Implementing Measures for the Protection of Pharmaceutical Trial Data

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

Access to 3000+ essential documents, including key PRC laws translated into English
Newsletters with business-critical and sector-specific updates
Premium mobile access with timely analysis on China’s fast-changing market

Already a Subscriber? Log In Here

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)